发明名称 ALPHAVIRUS REPLICON PARTICLES EXPRESSING TRP2
摘要 <p>The immune response to melanoma cells and tumors can be induced or significantly increased by administering to a subject a pharmaceutical composition comprising alphavirus particles, especially Venezuelan equine encephalitis virus replicon particles, which express the melanoma antigen dopachrome tautomerase (DCT, TRP2) in cells of the subject, with the result of tumor regression and /or inhibition of metastasis of a melanoma subject, or a decreased risk of the occurrence or recurrence of melanoma and/or decreased severity of melanoma in a subject not suffering from melanoma at the time of administration. The pharmaceutical composition described herein can be used in conjunction with other therapeutic agents, it can be administered on more than one occasion and it can be combined with administrations of other compositions such as protein or other immunogenic compositions, and/or adjuvants, with beneficial effects to the human or animal subject to which it has been administered.</p>
申请公布号 WO2010118252(A1) 申请公布日期 2010.10.14
申请号 WO2010US30423 申请日期 2010.04.08
申请人 ALPHAVAX, INC.;SLOAN KETTERING INSTITUTE FOR CANCER RESEARCH;WOLCHOK, JEDD D.;AVOGADRI, FRANCESCA;OLMSTED, ROBERT A.;MAUGHAN, MAUREEN 发明人 WOLCHOK, JEDD D.;AVOGADRI, FRANCESCA;OLMSTED, ROBERT A.;MAUGHAN, MAUREEN
分类号 A01N63/00;A61K39/12 主分类号 A01N63/00
代理机构 代理人
主权项
地址